Navigation Links
Senetek PLC Launches Dedicated Pyratine-6(TM) Website
Date:1/27/2009

NAPA, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging, announced today the launch of a dedicated Pyratine-6(TM) website, http://www.Pyratine-6.com, that provides information to consumers and medical professionals about Pyratine-6, Senetek's advanced cytokinin technology.

The website (http://www.Pyratine-6.com) is a comprehensive and convenient resource for information on Senetek's anti-aging cytokinin technology and the Pyratine-6(TM) product line, which includes Pyratine-6(TM) Lotion, Creme, Foaming Cleanser, Soft Creme + 10% Vitamin C. An SPF product will be introduced in Spring 2009 to complete the Pyratine-6(TM) line.

Detailed sections provide site visitors with a scientific analysis of cytokinins for therapeutic applications, and present the results of a 12-week independent clinical trial that demonstrates the efficacy of Pyratine-6(TM) for roughness, erythema, hyperpigmentation, skin moisture, and fine wrinkles. Also featured is Senetek's history in the development of innovative skincare technologies, including the cytokinins Kinetin and Zeatin. Additionally, a dedicated physician-only section will soon provide local resources, staff training tools and sales support to the medical community.

"The launch of the Pyratine-6(TM) website allows both consumers and physicians practical, reliable access to cutting-edge anti-aging information and products from Senetek," said Frank Massino, CEO of Senetek PLC. "The straightforward design of the site echoes and supports our research-based, results-driven technology."

About Senetek, PLC

Senetek PLC (OTCBB:SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
2. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
3. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
4. Isogen Launches Major New Facility to Address Global Biopharma Demand
5. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
6. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
7. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
8. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
9. Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center
10. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):